Silence Therapeutics plc·4

Jun 30, 12:31 PM ET

Griffiths Richard Ian 4

4 · Silence Therapeutics plc · Filed Jun 30, 2025

Insider Transaction Report

Form 4
Period: 2025-06-26
Transactions
  • Purchase

    American Depositary Shares

    2025-06-26+20,73511,600,908 total
    Exercise: $5.67Ordinary Shares (62,205 underlying)
  • Purchase

    American Depositary Shares

    2025-06-27+24,00011,624,908 total
    Exercise: $5.82Ordinary Shares (72,000 underlying)
  • Purchase

    American Depositary Shares

    2025-06-26+65,73911,580,173 total
    Exercise: $5.91Ordinary Shares (197,217 underlying)
Footnotes (1)
  • [F1]Each American Depositary Share ("ADS") is immediately convertible into three ordinary shares for no consideration and has no expiration date.

Documents

1 file
  • 4
    tm2519448-1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT